BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin T, Lv W, Liu D, Jing Y, Hu F. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway. Aging (Albany NY) 2020;12:12160-74. [PMID: 32554853 DOI: 10.18632/aging.103386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mu Q, Zhang C, Li R, Guo Z. CircPalm2 knockdown alleviates LPS-evoked pulmonary microvascular endothelial cell apoptosis and inflammation via miR-450b-5p/ROCK1 axis. International Immunopharmacology 2022;113:109199. [DOI: 10.1016/j.intimp.2022.109199] [Reference Citation Analysis]
2 Carigga Gutierrez NM, Pujol-Solé N, Arifi Q, Coll JL, le Clainche T, Broekgaarden M. Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling. Cancer Metastasis Rev 2022;41:899-934. [PMID: 36155874 DOI: 10.1007/s10555-022-10064-0] [Reference Citation Analysis]
3 Kim CH, Kim DE, Kim DH, Min GH, Park JW, Kim YB, Sung CK, Yim H. Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis. Exp Mol Med 2022;54:414-25. [PMID: 35379935 DOI: 10.1038/s12276-022-00750-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yang W, Wu L, Jin M. Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1. J Clin Lab Anal 2022;:e24262. [PMID: 35212425 DOI: 10.1002/jcla.24262] [Reference Citation Analysis]
5 Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Respir Res 2021;22:248. [PMID: 34537072 DOI: 10.1186/s12931-021-01840-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang QF, Wang QL, Cao MB. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis. Front Med (Lausanne) 2021;8:668787. [PMID: 34055841 DOI: 10.3389/fmed.2021.668787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]